Replies to post #63795 on Vivos Inc (RDGL)

[Popeye]

Exactly Right Catfish!

?There are 65 million dogs and 32 million cats in the United States. Of these, roughly 6 million new cancer diagnoses are made in dogs and a similar number made in cats each year. See http://ccr.nci.nih.gov.

Let's pretend AMIC captures 1% of that market share at 1.5 doses per dogl

6,000,000 New cancers ever year (dogs only)
1% market share = 60,000 dogs treated

Avg. cost per treatment = $150
Avg wholesale per treatment = $750
Avg profit per treatment = $600

Annual Revenue for treating 1% market share (dog only) = $45 million
Annual Gross Profit for treating 1% market share (dog only) = $36 million

Now wait, there's more :)

Add cats to that mix and it doubles

Annual Revenue for treating 1% market share (dogs and cats) = $90 million
Annual Gross Profit for treating 1% market share (dogs and cats) = $72 million

And since it's so affordable it's not out of the question to begin estimating with the fact that Radiogel could dominate the veterinary oncology space so let's go 5% market share

Annual Revenue for treating 5% market share (dogs and cats) = $450 million
Annual Gross Profit for treating 5% market share (dogs and cats) = $360 million

And now all the sudden AMIC with numbers like this is a $Billion company in the vet space ALONE.

BINGO BANGO BONGO!

$ADMD